Even with the continued unfold of extra contagious coronavirus variants throughout the nation, the previous week has introduced plenty of information to cheer on the pandemic entrance: a major decline in new circumstances; favorable information on the efficacy and efficiency of three further vaccines prone to velocity the U.S. rollout (Johnson & Johnson, Novavax, and AstraZeneca); and the truth that one other 2.5 million Individuals have acquired not less than one dose of a vaccine in opposition to COVID-19.
By means of Tuesday, Feb. 2, 8.2% of the U.S. inhabitants, or 27.2 million individuals, had acquired not less than one shot, in keeping with information from the Facilities for Illness Management, up from 24.7 million the week before. One other 6.4 million people had acquired each doses of the coronavirus vaccine. Of the 55.9 million doses of Pfizer and Moderna vaccines distributed throughout the U.S., roughly 61% have been administered.
The image is more and more combined throughout states by way of the standing of the COVID vaccine marketing campaign. Alaska stays out entrance with 13.4% of its inhabitants having acquired not less than one dose of the vaccine, the most important share throughout the nation. That equates to roughly 126,000 doses administered, which is nonetheless many fewer than in additional populous states. (In California, 3.7 million doses have been administered; in Texas, 2.7 million.) West Virginia, New Mexico, and Connecticut have additionally reached greater than 10% of their populations with the vaccine. For the second week, Idaho trails the remainder of the nation by way of the share of individuals vaccinated, with simply 6% of residents having acquired not less than one dose.
Whereas the steadily rising variety of vaccinated Individuals might be thought-about progress within the battle in opposition to COVID, the previous week has additionally introduced extra proof that the rollout, to date, reflects disparities in well being care entry and outcomes which have defined the pandemic in America: At the same time as populations of shade have accounted for a disproportionate variety of circumstances and deaths owing to COVID, a preponderance of accessible vaccines appear to be going to prosperous, white individuals.
SHARE OF THE POPULATION THAT RECEIVED AT LEAST ONE SHOT
|State or territory||Share vaccinated|
|District of Columbia||9.2%|
Extra health care and Big Pharma coverage from Fortune:
- The 3 major fixes damaged well being methods want, in keeping with specialists
- Do COVID vaccines stop coronavirus from spreading or just make you less sick?
- What we learn about the 5 biggest problems with the COVID vaccine rollout
- Johnson & Johnson’s lower-immunity single-dose COVID vaccine could be simply what the physician ordered
- Why Europe’s summer season COVID vaccination goal could still be on track